Technology & Innovation
Share your love
Transformative advances in vision research: It’s the science | Ophthalmology Times
(Image Credit: AdobeStock/kkolosov) As part of Ophthalmology Times’ 50th anniversary celebration, leaders in the field are reflecting on the transformative role of science and research in advancing eye care. Deborah A. Ferrington, PhD—chief scientific officer and the Stephen J. Ryan–Arnold…
From lab to clinic: Advancing ophthalmic technology | Ophthalmology Times
Emerging diagnostic and surgical technologies are enhancing precision, improving efficiency, and shaping the future of patient care in ophthalmology. (Image credit: AdobeStock/Olivier Le Moal) As ophthalmic technology continues to advance, new diagnostic and surgical devices are redefining precision, efficiency, and…
Topcon Healthcare seeks to advance company through acquisition and new investment | Ophthalmology Times
Image credit: AdobeStock/Lance Topcon Healthcare will acquire Toku, Inc., according to a press release issued by the company. Toku is a healthcare artificial intelligence (AI) company that uses color fundus photographs to deliver assessments of health. The release notes that…
Periorbital rejuvenation: Past, present, and next | Ophthalmology Times
(Image Credit: AdobeStock/Alessandro Grandini) The aesthetic treatment of the periorbital region has evolved significantly, shaped by centuries of innovation and driven by the desire to understand anatomy and how it is affected by aging. Among the earliest documented advancements in…
Throwback Series: Identifying and treating neovascular lesions in pregnancy | Ophthalmology Times
In celebration of Ophthalmology Times’ 50th anniversary, we invited leaders in ophthalmology to revisit a memorable “throwback” case from earlier in their careers. In this special series, they reflect on how evolving knowledge, techniques, and technologies have transformed the way…
AAO 2025: Understanding and diagnosing endophthalmitis | Ophthalmology Times
Note: Video captions are generated with the assistance of AI and may contain errors. At the 2025 annual meeting of the American Academy of Ophthalmology, Sunir J. Garg, MD, gave a presentation titled, “Endophthalmitis Sterile or not.” In an interview…
AAO 2025: Diana Do, MD, reviews the real-world use of aflibercept 8 mg | Ophthalmology Times
Note: Video captions are generated with the assistance of AI and may contain errors. Diana Do, MD, a professor of ophthalmology and vice chair of Clinical Affairs at Stanford University’s Byers Eye Institute, presented research on aflibercept 8 mg in…
Breaking down the barriers: Ophthalmic care in the incarcerated population | Ophthalmology Times
(Image Credit: AdobeStock/methaphum) The US has the highest incarcerated population globally, with Black, Indigenous, or Hispanic individuals significantly more likely to be imprisoned than White individuals. These racial disparities mirror those seen in vision health and access to eye care.1,2…
Charles Miller, MD, PhD, on DME research and the initiation of the phase 2b/3 BRUNELLO trial | Ophthalmology Times
Image credit: AdobeStock/MrAshi On September 4, 2025, Merck and EyeBio announced that the companies have initiated the Phase 2b/3 BRUNELLO trial (NCT06571045) to evaluate the candidate MK-3000, formerly known as EYE103 for the treatment of patients with diabetic macular edema…
David Lally discusses the ARCHER trial and the optimistic outcomes fueling future research | Ophthalmology Times
Note: Video captions are generated with the assistance of AI and may contain errors. David Lally, MD, presented at the 2025 Retina Society meeting, discussing the ARCHER study (NCT04656561) of ANX007 for the treatment of age-related macular degeneration (AMD) and…